Overview

Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate

Status:
Not yet recruiting

Trial end date:
2024-05-20

Target enrollment:

Participant gender:

Summary

The main aim of this study is to assess the effectiveness and safety of the 6-month formulation of triptorelin pamoate in Chinese participants with locally advanced or metastatic cancer of the prostate. Participants will receive 1 injection of triptorelin pamoate 6-month formulation.

Phase:

Phase 3

Details

Lead Sponsor:

Ipsen

Treatments:

Triptorelin Pamoate